Literature DB >> 29556313

Sterol regulatory element-binding protein 1 cooperates with c-Myc to promote epithelial-mesenchymal transition in colorectal cancer.

Duanyang Zhai1, Chunhui Cui1, Lang Xie1, Lianxu Cai1, Jinlong Yu1.   

Abstract

Metastasis is the primary cause of mortality in colorectal cancer (CRC), the mechanism of which remains unclear. In the present study, by detecting mRNA expression using a reverse transcription-quantitative polymerase chain reaction (qPCR), it was revealed that sterol regulatory element-binding protein 1 (SREBP1) is highly expressed in CRC. Using a cell wound healing assay and a cell invasion assay, a novel metastasis-promoting role for SREBP1 in CRC was identified. Furthermore, snail family transcriptional repressor 1 (SNAIL) was identified as a key downstream effector of SREBP1 in CRC by the use of small interfering RNA against SNAIL. Additionally, using co-immunoprecipitation and chromatin immunoprecipitation-qPCR assays, it was demonstrated that SREBP1 interacts with c-MYC to enhance the binding of c-MYC to the promoter of the mesenchymal gene, SNAIL, thereby increasing SNAIL expression and accelerating epithelial-mesenchymal transition. These results indicated a novel role for SREBP1 and provide insight into the regulatory mechanisms of the c-Myc oncogene in CRC, which may function as a potential therapeutic target for CRC treatment.

Entities:  

Keywords:  SNAIL; c-Myc; colorectal cancer; epithelial-mesenchymal transition; sterol regulatory element-binding protein 1

Year:  2018        PMID: 29556313      PMCID: PMC5844001          DOI: 10.3892/ol.2018.8058

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.

Authors:  Wei Zhu; Mu-Yan Cai; Zhu-Ting Tong; Sui-Sui Dong; Shi-Juan Mai; Yi-Ji Liao; Xiu-Wu Bian; Marie C Lin; Hsiang-Fu Kung; Yi-Xin Zeng; Xin-Yuan Guan; Dan Xie
Journal:  Gut       Date:  2011-08-03       Impact factor: 23.059

3.  SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism.

Authors:  Yan Sun; Weiwei He; Man Luo; Yuhong Zhou; Guilin Chang; Weiying Ren; Kefen Wu; Xi Li; Jiping Shen; Xiaoping Zhao; Yu Hu
Journal:  Tumour Biol       Date:  2015-01-15

4.  Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis.

Authors:  Weihua Li; Yanhong Tai; Jie Zhou; Weiting Gu; Zhaofang Bai; Tao Zhou; Zhijiu Zhong; Peter A McCue; Nianli Sang; Jun-Yuan Ji; Beihua Kong; Jie Jiang; Chenguang Wang
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

5.  Sphingosine kinase 2 promotes colorectal cancer cell proliferation and invasion by enhancing MYC expression.

Authors:  Lan Zhang; Xuezheng Liu; Zhongfu Zuo; Chunyan Hao; Yanmei Ma
Journal:  Tumour Biol       Date:  2016-01-05

6.  IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.

Authors:  Chao Yao; Li Su; Juanjuan Shan; Chuanlin Zhu; Limei Liu; Chungang Liu; Yanmin Xu; Zhi Yang; Xiuwu Bian; Jimin Shao; Jianming Li; Maode Lai; Junjie Shen; Cheng Qian
Journal:  Stem Cells       Date:  2016-02-26       Impact factor: 6.277

7.  SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer.

Authors:  Jisheng Bao; Liping Zhu; Qi Zhu; Jianhua Su; Menglan Liu; Wei Huang
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

8.  TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer.

Authors:  Cheng-En Hu; Jun Gan
Journal:  Mol Med Rep       Date:  2017-01-16       Impact factor: 2.952

9.  Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Authors:  Adam T Boutin; Wen-Ting Liao; Melody Wang; Soyoon Sarah Hwang; Tatiana V Karpinets; Hannah Cheung; Gerald C Chu; Shan Jiang; Jian Hu; Kyle Chang; Eduardo Vilar; Xingzhi Song; Jianhua Zhang; Scott Kopetz; Andrew Futreal; Y Alan Wang; Lawrence N Kwong; Ronald A DePinho
Journal:  Genes Dev       Date:  2017-03-13       Impact factor: 11.361

10.  Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth.

Authors:  Beatrice Griffiths; Caroline A Lewis; Karim Bensaad; Susana Ros; Qifeng Zhang; Emma C Ferber; Sofia Konisti; Barrie Peck; Heike Miess; Philip East; Michael Wakelam; Adrian L Harris; Almut Schulze
Journal:  Cancer Metab       Date:  2013-01-23
View more
  9 in total

Review 1.  Significant position of C-myc in colorectal cancer: a promising therapeutic target.

Authors:  Li Tan; Dong Peng; Yong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-16       Impact factor: 3.340

Review 2.  Targeting the Mevalonate Pathway in Cancer.

Authors:  Dennis Juarez; David A Fruman
Journal:  Trends Cancer       Date:  2021-01-06

3.  Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt/β-catenin signaling.

Authors:  Yanzhu Lin; Fanqing Meng; Zhiyuan Lu; Kai Chen; Yalan Tao; Yi Ouyang; Xinping Cao
Journal:  Cancer Manag Res       Date:  2018-10-04       Impact factor: 3.989

4.  Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.

Authors:  Patrick Lebok; Aurelia von Hassel; Jan Meiners; Claudia Hube-Magg; Ronald Simon; Doris Höflmayer; Andrea Hinsch; David Dum; Christoph Fraune; Cosima Göbel; Katharina Möller; Guido Sauter; Frank Jacobsen; Franziska Büscheck; Kristina Prien; Till Krech; Rainer Horst Krech; Albert von der Assen; Linn Wölber; Isabell Witzel; Barbara Schmalfeldt; Stefan Geist; Peter Paluchoswski; Christian Wilke; Uwe Heilenkötter; Luigi Terracciano; Volkmar Müller; Waldemar Wilczak; Eike Christian Burandt
Journal:  Aging (Albany NY)       Date:  2019-09-18       Impact factor: 5.682

Review 5.  The dual functional role of MicroRNA-18a (miR-18a) in cancer development.

Authors:  Kexin Shen; Zhe Cao; Ruizhe Zhu; Lei You; Taiping Zhang
Journal:  Clin Transl Med       Date:  2019-12-23

6.  Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.

Authors:  Shu-Ting Pan; Ji Zhou; Fang Yang; Shu-Feng Zhou; Tao Ren
Journal:  BMC Cancer       Date:  2020-07-08       Impact factor: 4.430

Review 7.  Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.

Authors:  Qiushi Zhao; Xingyu Lin; Guan Wang
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

8.  SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells.

Authors:  Zhenzhen Pan; Kai Wang; Qiufang Chen; Xiulan Zheng; Zhengyu Song; Xuansheng Ding
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

Review 9.  MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.

Authors:  Erna Marija Meškytė; Sabiha Keskas; Yari Ciribilli
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.